Evidence map›Paper›PMID 40092527›Full record

ArticleBioinformatics advances2025

Masked language modeling pretraining dynamics for downstream peptide: T-cell receptor binding prediction.

Brock Landry, Jian Zhang

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brock LandryDivision of Computer Science & Engineering, Louisiana State University, Baton Rouge, LA 70803, United States.ORCID https://orcid.org/0009-0002-5495-5892
Jian ZhangDivision of Computer Science & Engineering, Louisiana State University, Baton Rouge, LA 70803, United States.ORCID https://orcid.org/0000-0002-2673-8818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Predicting antigen peptide and T-cell receptor (TCR) binding is difficult due to the combinatoric nature of peptides and the scarcity of labeled peptide-binding pairs. The masked language modeling method of pretraining is reliably used to increase the downstream performance of peptide:TCR binding prediction models by leveraging unlabeled data. In the literature, binding prediction models are commonly trained until the validation loss converges. To evaluate this method, cited transformer model architectures pretrained with masked language modeling are investigated to assess the benefits of achieving lower loss metrics during pretraining. The downstream performance metrics for these works are recorded after each subsequent interval of masked language modeling pretraining. Results: The results demonstrate that the downstream performance benefit achieved from masked language modeling peaks substantially before the pretraining loss converges. Using the pretraining loss metric is largely ineffective for precisely identifying the best downstream performing pretrained model checkpoints (or saved states). However, the pretraining loss metric in these scenarios can be used to mark a threshold in which the downstream performance benefits from pretraining have fully diminished. Further pretraining beyond this threshold does not negatively impact downstream performance but results in unpredictable bilateral deviations from the post-threshold average downstream performance benefit. Availability and implementation: The datasets used in this article for model training are publicly available from each original model's authors at https://github.com/SFGLab/bertrand, https://github.com/wukevin/tcr-bert, https://github.com/NKI-AI/STAPLER, and https://github.com/barthelemymp/TULIP-TCR.

Identifiers

PMID40092527
PMCPMC11908642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.